Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Omnicell (OMCL)
:OMCL
Holding OMCL?
Track your performance easily
OMCL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$25.12 - $55.75
Previous CloseN/A
Volume97.52K
Average Volume (3M)463.79K
Market Cap
$1.95B
Enterprise Value$2.05B
Total Cash (Recent Filing)$54.49M
Total Debt (Recent Filing)$245.73M
Price to Earnings (P/E)―
Beta0.24
Next Earnings
Feb 06, 2025EPS Estimate
0.58Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.39
Shares Outstanding46,316,826
10 Day Avg. Volume353,042
30 Day Avg. Volume463,790
Standard Deviation0.14
R-Squared0.09
Alpha-0.00987
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.85
Price to Cash Flow (P/CF)21.70
P/FCF Ratio35.50
Enterprise Value/Market Cap1.05
Enterprise Value/Revenue1.92
Enterprise Value/Gross Profit4.12
Enterprise Value/Ebitda28.23
Forecast
1Y Price Target
$53.00Price Target Upside24.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
Omnicell News
PremiumCompany Announcements
Omnicell Reports Strong Q3 2024 Financial ResultsBulls Say, Bears Say
Bulls Say
Financial PerformanceOmnicell’s long-term targeted financial algorithm is favorable at a mid-teens revenue growth rate and roughly 400bps of annual margin expansion from 2021 equating to high-teens compounding EBITDA growth.
Product InnovationOmnicell announced a new product release, OmniSphere, a next-generation, cloud native, software workflow engine and data platform.
Revenue GrowthRobots are projected to contribute significantly to Omnicell's revenue in 2024, adding approximately $66 million.
Bears Say
Execution RiskHealthy level of execution risk amidst improving broader fundamentals in the business.
Inflation And Macro PressuresInflationary and macro pressures are weighing on the model near term, resulting in more compressed growth in the near term.
Product Revenue GrowthThere is still limited visibility into product revenue growth in the near-term.
---
Ownership Overview
1.98% Insiders
29.80% Mutual Funds
0.39% Other Institutional Investors
34.05% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OMCL FAQ
What was Omnicell’s price range in the past 12 months?
Omnicell lowest stock price was $25.12 and its highest was $55.74 in the past 12 months.
What is Omnicell’s market cap?
Omnicell’s market cap is $1.95B.
When is Omnicell’s upcoming earnings report date?
Omnicell’s upcoming earnings report date is Feb 06, 2025 which is in 15 days.
How were Omnicell’s earnings last quarter?
Omnicell released its earnings results on Oct 30, 2024. The company reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.419 by $0.141.
Is Omnicell overvalued?
According to Wall Street analysts Omnicell’s price is currently Undervalued.
Does Omnicell pay dividends?
Omnicell does not currently pay dividends.
What is Omnicell’s EPS estimate?
Omnicell’s EPS estimate is 0.58.
How many shares outstanding does Omnicell have?
Omnicell has 46,316,826 shares outstanding.
What happened to Omnicell’s price movement after its last earnings report?
Omnicell reported an EPS of $0.56 in its last earnings report, beating expectations of $0.419. Following the earnings report the stock price went up 32.228%.
Which hedge fund is a major shareholder of Omnicell?
Currently, no hedge funds are holding shares in OMCL
---
Omnicell Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$53.00 (24.50% Upside)
$53.00 (24.50% Upside)
Blogger Sentiment
Bullish
OMCL Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 43.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $567.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 4.7%
Last 30 Days ▼ 4.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.70%
12-Months-Change
Fundamentals
Return on Equity
-1.46%
Trailing 12-Months
Asset Growth
3.69%
Trailing 12-Months
Company Description
Omnicell
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence; platform and interoperability; central pharmacy dispensing; medication adherence; population health; and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Mountain View, CA.
---
OMCL Company Deck
---
OMCL Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
Omnicell's third quarter 2024 results reflect a strong performance in service revenues and positive developments in the XT Amplify program, despite challenges in product revenues and a decrease in non-GAAP earnings metrics. The company shows resilience with improved cash position and revised profitability guidance, indicating a focus on long-term growth and operational efficiency.Read More>---
OMCL Stock 12 Month Forecast
Average Price Target
$53.00
▲(24.50% Upside)
Technical Analysis
Best Analysts Covering OMCL
1 Year
1 Year Success Rate
9/17 ratings generated profit
1 Year Average Return
+14.19%
reiterated a buy rating 3 months ago
Copying Bill Sutherland's trades and holding each position for 1 Year would result in 52.94% of your transactions generating a profit, with an average return of +14.19% per trade.
---